Danske Bank A/S Novavax Inc Transaction History
Danske Bank A/S
- $1.95 Trillion
- Q3 2025
A detailed history of Danske Bank A/S transactions in Novavax Inc stock. As of the latest transaction made, Danske Bank A/S holds 1,200 shares of NVAX stock, worth $8,364. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200Holding current value
$8,364% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding NVAX
# of Institutions
307Shares Held
98.5MCall Options Held
5.7MPut Options Held
9.06M-
Vanguard Group Inc Valley Forge, PA15.2MShares$106 Million0.0% of portfolio
-
Shah Capital Management14.6MShares$101 Million48.17% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$82.6 Million0.0% of portfolio
-
State Street Corp Boston, MA7.2MShares$50.2 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.27MShares$29.8 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $545M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...